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Generating the perception of choice: the remarkable malleability of option-
listing  
 
Abstract (199 words) 
The normative view that patients should be offered more choice both within and 
beyond WKH8.¶V1DWLRQDO+HDOWK6HUYLFH1+6KDVEHHQLQFUHDVLQJO\HQGRUVHG
However, there is very little research on whether - and how - this is enacted in 
practice.  Based on 223 recordings of neurology outpatient consultations and 
SDUWLFLSDQWV¶VXEVequent self-reports, WKLVSDSHUVKRZVWKDWµRSWLRQ-OLVWLQJ¶LVDNH\
practice for generating the perception of choice.  The evidence is two-fold: first, we 
show that neurologists and patients overwhelmingly reported that choice was offered 
in those consultations where option-listing was used; second, we demonstrate how 
option-listing can be seen, in the interaction itself, to create a moment of choice for 
the patient.  Surprisingly, however, we found that even when the patient resisted 
making the choice or the neurologist adapted the practice of option-listing in ways 
that sought DFFHSWDQFHRIWKHQHXURORJLVW¶VRZQUHFRPPHQGDWLRQ, participants still 
agreed that a choice had been offered.  There was only one exception: despite using 
option-listing, the patient reported having no choice, whereas the neurologist reported 
having offered a choice.  We explore this deviant case in order to shed light on the 
limits of option-listing as a mechanism for generating the perception of choice.  
 
Keywords 
Conversation analysis; doctor-patient interaction; patient choice; option-listing; 
neurology 
Word count: 7, 783 + 250 words for Figure = 8, 033  
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Introduction 
The view that patients should be offered more choice within publicly-funded 
healthcare settings has been increasingly endorsed over the last two decades (Dent 
2006).  Indeed, Costa-Font and Zigante (2016: 409) describe the expansion of the 
µFKRLFHDJHQGD¶DV³DGRPLQDQWUHIRUP´taking place across many European National 
+HDOWK6HUYLFH1+6V\VWHPV³ZKHUHFKRLFHKDVWUDGLWLRQDOO\EHHQOLPLWHGUHODWLYH
to Social Health Insurance (SHI) systems where choice is traditionally 
LQVWLWXWLRQDOLVHG´  More broadly, the notion of patient choice connects (albeit in 
complex ways, as we recognise in our Discussion, below) with the widespread view 
that VRPHYHUVLRQRIµVKDUHGGHFLVLRQ-PDNLQJ¶LVWKHLGHDODSSURDFKWRKHDOWKFDUHLQ
the 21st century (e.g. Elwyn and Edwards 2009).  Policy documents relating to the 
United Kingdom¶VNHS ± the setting for the study reported here ± endorse both the 
general principles of shared decision-making and a commitment to patient choice, 
specifically.  This is exemplified in the opening of the NHS Choice Framework 
(2016), which moves quite fluidl\EHWZHHQWKHQRWLRQRIµFKRLFH¶DQGZLGHULGHDOV
VXFKDVµSDWLHQWHPSRZHUPHQW¶.  Similarly, the Department of Health (2007: 6) 
document, Choice Matters, lays out a broad vision for the implementation of patient 
choice within the NHS, and specifies forms of choice to be made available (e.g. which 
hospital to attend when referred by a GP) within a target timescale.  Patient choice in 
the 8.¶VNHS is, then, both carefully delimited and articulated as a broad aspiration.  
  
Despite this, there has been little attempt to address the question: what constitutes 
µSDWLHQWFKRLFH¶ in practice?  While SDWLHQWV¶OHJDOULJKWVWRFKRRVHPD\EHUHODWLYHO\) 
easy to pin down, the enactment of choice ± during face-to-face decision-making ± is 
far from self-evident.  The few studies that have investigated choice in interaction 
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have shown significant discrepancies between policy and practice.  Pilnick (2008) 
notes that WKH8.¶V NICE (National Institute for Health and Care Excellence) 
guidelines give pregnant women the right to choose whether to undergo screening for 
Down syndrome.  Accordingly, she found that midwives routinely articulated this 
right to women.  Nevertheless, they tended to present the decision such that it became 
PRUHDPDWWHURIµDVVHQW¶WKDQRILQGHSHQGHQWFKoice.  Investigating how care home 
staff enact the requirement to offer choice to people with intellectual difficulties, 
Antaki et al. (2008) similarly found that ± despite staff orientations WRUHVLGHQWV¶ULJKW
to choose ± the decision-making practices employed often worked against the resident 
making a choice.  
 
Patients report an important distinction between having a choice and making one, and 
between the appearance of choice and substantive choice (Barnett et al. 2008).  
Crucially, while patients ± in a study of NHS primary care in the UK ± valued having 
a (substantive) choice, they often reported not wanting to make the decision.  
Similarly, Ford et al. (2003) found that participants (lay people, academics and NHS 
practitioners) believed choice shouOGLQFOXGHWKHSDWLHQW¶VULJKWWRGHFLGHKRZPXFK
involvement in decision-making they want.  Such studies indicate a multi-dimensional 
understanding of choice and urge caution in assuming that it will always be desirable 
IURPWKHSDWLHQW¶VSHUVSHFWLYH 
 
As Pilnick (2008: 512) has argued:  
 
 What the offering and exercising of choice actually looks like in practice . . . 
 remains unclear.  The potential implications of these interactional processes, 
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 WKRXJKDUHLPPHQVHVLQFHµJRRG¶ practice is ultimately achieved through 
 interaction rather than through policy or regulation. 
 
The present paper takes up the challenge in this quote, seeking to develop our 
understanding of how choice is enacted.  We provide an analysis of decision-making 
sequences in nHXURORJ\FRQVXOWDWLRQVDQGFRQVLGHUWKHVHLQOLJKWRISDWLHQWV¶DQG
QHXURORJLVWV¶UHSRUWVof whether a choice was offered.  We show that option-listing ± 
a practice identified in our pilot study (Anonymous) ± was strongly associated with 
the reported perception that choice had been offered.  This is not surprising given that 
option-listing, being akin to providing a menu, is a widespread mechanism for 
offering choice across a range of institutions: from restaurants to hair salons, car 
washes to telephone banking.  More surprising, we argue, is our finding that the 
association between option-listing and the perception of choice remained even in 
instances where patient choice was not ± or, at least, not unambiguously ± being 
enacted in practice.  We refer WRWKLVDVWKHµPDOOHDELOLW\¶RIRSWLRQ-listing because the 
practice may be adapted, and responded to, in highly variable ways, including the 
following:    
 
x Option-listing may serve to offer a choice, but this may not be taken up by the 
patient; 
x Option-listing may serve to offer a choice, but this may be followed 
immediately by a recommendation for one option; 
x The machinery of option-listing may be used, but ± in contrast with its use to 
lay out alternatives from which the patient might choose ± it can serve to 
SXUVXHDFFHSWDQFHRIWKHQHXURORJLVW¶VUHFRPPHQGHGoption.    
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WHH[SORUHWKLVµPDOOHDELOLW\¶RIRSWLRQ-listing, showing that neurologists and patients 
still agreed that choice had been offered even when the patient did not actually make 
the choice or when the neurologist sought acceptance of their own preferred option.  
Only in one consultation containing option-listing (out of 19 for which we have valid 
self-report data, see Figure 1) did patient and neurologist not agree that choice had 
been offered.  We explore this deviant case in order to shed light on the limits of 
option-listing as a mechanism for generating the perception of choice.  
  
Methods 
 
Study context 
This paper reports findings from a study of patient choice in neurology, funded by the 
8.¶V1DWLRQDO,QVWLWXWHIRU+HDOWK5HVHDUFK (see also Anonymous).  Data were 
collected in the outpatient departments of two neuroscience centres, in Glasgow and 
Sheffield.  Neurology was chosen because SDWLHQWV¶LQYROYHPHQWLQdecisions about 
their care is considered important in chronic diseases generally, and certain 
neurological conditions specifically (Department of Health 2005).  This is the case 
across a wide range of national settings (see Pietrolongo et al. 2013).  Yet there is 
evidence that neurology patients may experience decision-making as clinician-
dominated (McCorry et al. 2004) and that efforts to involve patients may not always 
be ³DSURPLQHQWSDUWRISDWLHQWFDUH´Pietrolongo et al. 2013: 6).  This makes 
neurology an important site for investigating how the patient choice agenda is being 
implemented. 
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Data collection  
Our main data source was audio- and video-recordings of consultations, collected in 
2012.  Participants also completed questionnaires after their consultation, which 
LQFOXGHGWKHTXHVWLRQV³'LG\RXJLYHWKHSDWLHQWDFKRLFHDERXWWUHDWPHQWRUIXUWKHU
PDQDJHPHQW"´DQG³'LGWKHGRFWRUJLYH\RXDFKRLFHDERXWDQ\WHVWVRUWUHDWPHQW\RX
might have or the next step in the management of your condiWLRQ"´  Patients were sent 
an information sheet at least 48 hours prior to their appointment.  On arrival at the 
clinic they were invited to discuss the study with a research assistant, who took 
written consent.  In total, 66% of those approached agreed to take part.  Participants 
could opt for audio or video-recording.  Ethical approval was granted by the NRES 
Committee for Yorkshire & the Humber (South Yorkshire) on 11th October 2011.    
 
Data analysis 
Our primary approach was conversation analysis (CA).  CA is a micro-analytic, 
systematic methodology, widely recognised as the leading approach for investigating 
how doctor-patient interaction functions (Heritage and Maynard 2006).  CA 
understands talk not simply as information transfer, but as a way of performing social 
actions.  Since any action may be performed in different ways, analysis focuses on 
how something gets done, and the interactional consequences thereof.  In our wider 
study, we identified all instances of decision-making about current treatments, 
investigations and referrals, and examined how the decision-making process was 
initiated, pursued and concluded.  We found three key practices that neurologists used 
to initiate and pursue decisions: recommendations (e.g. you should try x), option-lists 
(e.g. you could try x or you could try y), and patient view elicitors (e.g. what do you 
want to do? How do you feel about trying x?) (Anonymous).  This paper reports our 
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analysis of the 19 consultations that contained at least one instance of option-listing, 
for which we have valid self-UHSRUWGDWDUHJDUGLQJWKHQHXURORJLVWV¶DQGSDWLHQWV¶
perception of whether the neurologist offered the patient a choice (see Figure 1).   
 
Figure 1 to go here. 
 
To compare SDUWLFLSDQWV¶ reports of choice with what took place in the interactions, 
we divided the recordings into four subsets, discussed below (Table 1).  We sought 
patterns across these with respect to how the decision-making was accomplished.  The 
aim was to discover, inductively, what might have been hearable in the consultations 
DVµFKRLFH¶  Our discovery that option-listing was associated almost exclusively with 
the agreement that a choice had been offered led to the more detailed analyses that we 
report here.    
 
Findings 
 
The perception of choice 
Overall, there was a fairly high level of perceived choice on offer in our dataset: in 
67.9% (146/215) of cases for which we have the relevant questionnaire data, the 
neurologist reported offering the patient a choice, and in 71.8% (145/202) of cases for 
which we have the data, the patient reported being offered a choice.  Table 1 shows 
the nature of this agreement across the four possible permutations for the 196 
consultations for which data were available from both neurologist and patient.  As the 
table shows, in just over half of these cases, there was agreement that a choice had 
been offered.  See Anonymous for a statistical exploration of this dataset.   
 8 
 
Table 1: Agreement and disagreement about presence of choice 
Total n=196 Neurologist: Choice - Yes Neurologist: Choice - No 
Patient: Choice - Yes Subset 1. Agree (53.6%, n=105) Subset 2. Disagree (17.9%, n=35) 
Patient: Choice - No Subset 3. Disagree (14.3%, n=28) Subset 4. Agree (14.3%, n=28) 
 
Our qualitative analysis revealed a striking finding: with just one exception (i.e. 1/19, 
see Figure 1), option-listing was only present in those consultations (for which we 
have valid data) where neurologist and patient agreed a choice had been offered 
(Table 1, Subset 1).  This leaves numerous FRQVXOWDWLRQVLQWKHµDJUHHFKRLFH¶VXEVHW
in which decision-making was handled in another way (e.g. using forms of 
recommendation or patient view elicitor).  However, the finding of such a clear 
association between option-listing and self-reported perception of choice was reason 
enough to examine the practice further.  When considered in light of how option-
listing was enacted, this pattern became even more remarkable, as we show across the 
remaining analytic sections.  
 
Having vs. making a choice 
As demonstrated previously (Anonymous), option-listing consists, in its full form, of 
three components.  Component 1 entails some indication by the neurologist that there 
is a decision yet to be made.  Component 2 entails the subsequent formulation of a list 
of optionsVRPHWLPHVODEHOOHGDVVXFKHJ³RSWLRQRQHLV«RSWLRQWZRLV«RSWLRQn 
LV«´and sometimes embedded within an LQWHUURJDWLYHHJ³ZRXOG\RXOLNHWR[«
ZRXOG\RXOLNHWR\«ZRXOG\RXOLNHWR]«´, some of which were either/or choices.  
Doing nothing was sometimes included explicitly.  Component 3 entails inviting the 
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patient to announce their views on the options and/or to select one.  We refer to this 
component as a patient view elicitor (PVE), encompassing turns that ask what the 
patient wants, how they feel, and what they think about the options. 
   
The three-component package is illustrated in Extract 1.  Having already advised 
changing one of WKHSDWLHQW¶VDQWL-epileptic drugs, the neurologist sets up a decision 
regarding what to take instead.  At lines 1-2 he projects a forthcoming list (component 
1).  At lines 7, 40 and 72, he names three options (component 2).  At lines 115-6, he 
LQYLWHVWKHSDWLHQW¶s view on the options (component 3), which the patient provides 
(see lines 117-18, 127, 151-2, 156, 180).  For a key to the transcription conventions 
used in CA, please see: http://www.paultenhave.nl/Transcription-DCA-2.htm.  The 
identifiers show where the consultation was recorded (Glasgow or Sheffield), the 
number of the recording (numbered consecutively at each site from 001), followed by 
a two-digit number for each clinician.   
  
Extract 1 
G10905: Epilepsy  
01   Neu:   .hhh U:m:: (1.0) possibilities. (0.9) .tch Okay let me  
02          talk through these. 
03          (0.2) 
04   Pat:   [Yeah. 
05   Neu:   [.hhh E:r (2.0) OHW¶VVWDUWZLWKthe oldest one first. 
06          (0.3) 
07   Neu:   Er carbamazepine. (0.2) Tegretol. (.) .hhh drug (0.2)  
08          good drug, (0.4) still useful against localisation  
09          related epilepsy, .hh e::r invented, rouJKO\µVµV 
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(Neurologist describes pros and cons of the drug) 
 
39   Neu:   .tchhhh Other (0.1) possibilities. (0.2) E::r another  
40          drug call:ed u::m (.) vigabatrin, (0.2) Sabril, (0.5)  
41          slightly newer drug, 
42   Pat:   Mh[m, 
43   Neu:     [brought in in the late 1980s, .hhh good drug (0.3)  
 
(Neurologist describes pros and cons of the drug) 
 
70   Neu:   .hhh Um VRWKDW¶V7HJUHtol (1.0) the vigabatrin, (0.2)  
71          and the last one to talk about is a drug called  
72          retigabine. (.) .hhh u::m which is a new drug, (0.7) 
73          given a licence: (0.7) e:::r about (.) nine months ago, 
74          (0.2) 
1HXKKHU,¶YHXVHGLWDKDQGIXORIWLPHV 
76          (0.2) 
77   Neu:   .hhhh Er, quite early days yet. It works in a completely 
GLIIHUHQWZD\IURPRWKHUDQWLHSLOHSWLFGUXJV« 
 
(Neurologist describes pros and cons of the drug) 
 
115  Neu:   .hhhhh hh. Of those three:::, (0.6) do you  
116         have any 0.2) thoughts=do you have any: hhh. (0.5)  
117  Pat:   We::ll ,¶PQRWWRRNHHQRQWKHsecond one that  
118         you mentioned, 
119  Neu:   Mm:. 
120         (0.3) 
121  Pat:   U::m (0.1) 
122  Neu:   >With the< vision,  
123         (0.2) 
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124  Pat:   Mhm::, 
125         (0.7) 
126  Neu:   [Okay 
127  Pat:   [Yeah that does kinda:: (0.3) [put me off. 
128  Neu:                                 [I know 
129         (0.1) 
130  Neu:   and the weight gain. 
131  Pat:   Yeah. 
1HX,¶YHQRW- >WREHKRQHVW,¶YHQRW>GRQHDJUHDWMRERI 
133  Pat:             [Yea::h                >WKDW¶VRQHDVZHOO 
134  Neu:   £selling it but it-\RXNQRZ« 
 
1HXURORJLVWH[SODLQVKRZWKLVGUXJZKLOHQRWEHLQJWKHPRVWVWUDLJKWIRUZDUGRSWLRQLVRQ³WKH
VKRUWOLVW´ 
 
151  Pat:   The- the:: third one (0.4) the new one (0.3) is::  
152         KK>KKFDWFKLQJP\H\H EXWWKHQDJDLQ\RXGRQ¶WNQRZ 
153  Neu:      [((moves head from side to side in a gesture that  
154         seems to suggest equivocation)) 
155  Neu:   .tc[h 
156  Pat:      >µFDXVHLW- because LW¶VDQHZRQH 
157  Neu,¶YHDELWOHVVH[SHULH- er- w(hh[hh.  we(heh)ll (0.1)  
158  Pat:                                    [Yea:h. 
1HX,¶YHJRWDOKRWOHVVH[SKHULKHQFHZLWK 
160         tha:t.£ .hhh 
 
(Neurologist explains that he is happy to try this drug but would usually suggest it when other options 
ZHUH³FORVHGRII´ 
 
179  Neu:   I[:: 
180  Pat:    >6RUHDOO\LW¶VWKHILUVWRQHWKDWZH¶UH 
 12 
181  Neu:   I- ,WKLQNLW¶VWKHILUVWRQH DQGLW¶VQRWDSHUIHFW 
182         drug. 
183         (0.1) 
184  Neu:   .hh u:m but for- e- sorry (0.1) not a perfect drug for  
185         everyone. 
186  Pat:   Oka(h)(h)y. 
 
(Neurologist gives PRUHLQIRUPDWLRQDERXWWKHGUXJ¶VHIIHFWLYHQHVVEXWWKHGHFLVLRQLVWUHDWed as made) 
 
The components combine to offer the patient an explicit choice.  In component 1, the 
neurologist names the information to come as a listing of ³SRVVLELOLWLHV´UDWKHUWKDQD
recommendation.  ,QFOHDULQJVSDFHWR³WDONWKURXJKWKHVH´OLQHhe signals that the 
information is to be understood as part of a deliberation process (in contrast to 
prospective accounting for a decision already reached, as shown in Hudak et al. 
2011).  In component 2, the neurologist describes the options and their advantages and 
disadvantage, working hard to present each as reasonable for this patient, thus further 
constructing a choice.  Finally, component 3 creates a slot for the patient to voice his 
views, with the potential to make the choice himself.  As we have shown previously 
(Anonymous), this contrasts with making a recommendation in that ³UHFRPPHQGLQJ
turns do not invite SDWLHQWVWRGRPRUHWKDQVLPSO\DFFHSWWKHGRFWRU¶VSURSRVDO´
(Anonymous, emphasis added).  When responding to component 3, simple acceptance 
is inadequate.  Instead, the decision-PDNLQJLVSODFHGLQWKHSDWLHQW¶VGRPDLQ.   
 
Thus, option-listing can, demonstrably, be used to offer patients choice.  This analysis 
accords with the self-report finding (discussed above) that neurologists and patients 
almost always agreed that a choice had been offered following consultations in which 
option-listing was used.  Crucially, however, patients did not always take up this 
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opportunity to choose.  Extract 2 provides a contrast to Extract 1.  Both patients are 
young men, accompanied by their parents.  Both have epilepsy and are offered ± by 
the same neurologist ± a choice of anti-epileptic drugs as a replacement for one that 
has not been working well.  In both, the neurologist uses option-listing in a similar 
way, announcing a choice to be made, listing more than one option, and seeking the 
SDWLHQW¶Vviews on/selection from the list.  Extract 2 shows this final component (lines 
108 and 110) and the responses produced by patient and parents.   
 
Extract 2 
G10305: Epilepsy  
(Previous lines entail presenting two options) 
108  Neu:  .thhh Either >one of them,< (0.3) grab you? 
109        (0.6) 
110  Neu:  Any: particular preference, (0.5) one or other,  
111         (1.1) 
112  (Pat): hhh[hhhh. ((sounds like breathy form of laughter))  
1HX>,W¶VGLIILFXOWµFRVWKH\both work in relatively  
114         similar ways:. 
115         (0.1)  
0XP,¶PQRW>VXUHDERXWWKHVLGHHIIHFWVEXWKDVDQ\RI 
117  (Pat):         [(Um:) 
0XPWKHPJRWQRVHZHLJKWORVVµFRVKH¶V 
119         (kinda) [(a(h)wfully) thi(h)n [(a(h)s it [is 
120  (Pat)/(Dad):   [No(h)      
121  Neu:                                 [Right     [No 
122  Mum:   without losing any more wei(h)ght heh heh  
 
1HXURORJLVWH[SODLQVWKDWKHZRXOGQ¶WH[SHFWHLWKHUGUXJWRUHGXFHDSSHWLWH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133  Mum:   Right. 
134         (0.6) 
'DG'HSHQGVRQ\RX\RX¶UHDVVNQRZVD\LQJ 
136         (professionally) what you think, 
 
The contrast in responses to the option-listing shown in Extracts 1 and 2 is marked.   
In 1, the patient takes up the opportunity to choose.  Across lines 117-8, 151-2, and 
ZHVHHKLPPLUURULQJWKHQHXURORJLVW¶VOLVWE\FRQVLGHULQJHDFKoption himself, 
finally concluding that the first is the one to try (line 180).  This decision-making is 
clearly guided by the neurologist, as he humorously recognises (lines 132, 134).  
,QGHHGWKHSDWLHQW¶VVHOHFWLRQLVEXLOWDVDORJLFDOFRQFOXVLRQRIWKHOLQHRI reasoning 
WKDWKDVRFFXUUHGUDWKHUWKDQVLPSO\DVKLVSHUVRQDOSUHIHUHQFH³VRUHDOO\LW¶VWKHILUVW
RQH«´OLQH1HYHUWKHOHVVLWLVWKHSDWLHQWZKRDUWLFXODWHVWKDWFRQFOXVLRQ
treating it as based on his evaluation of the evidence, his concerns about potential side 
effects, and the risks of trying a new drug.   
 
By contrast, In Extract 2, the patient has difficulty in responding, evident in the 
silence at lines 109 and 111, and breathy laughter at 112.  Subsequently, his mother 
asks a question (lines 116-122) and his father seeks the QHXURORJLVW¶VYLHZOLQHV-
6).  This results in a recommendation, which the family accepts, thus making this a 
PDWWHURIµDVVHQW¶UDWKHUWKDQan expression of an independent µFKRLFH¶ (Pilnick, 
2008).  Nevertheless, WKHIDPLO\¶VUHVSRQVHVLQGLFDWHDQXQGHUVWDQGLQJWKDWWKHSDWLHQW
KDVEHHQLQYLWHGWRFKRRVH)LUVWWKHSDWLHQW¶VGLIILFXOW\LQUHVSRQGLQJis treated by 
the neurologist as a difficulty of choosing (lines 113-4).  Second, whHQWKHSDWLHQW¶V
mother steps in, she orients to a possible basis for choosing that has not been explored 
(a possible side effect)LQDOO\WKHIDWKHU¶VUHVSRQVHFRXQWHUVWKHDFWLRQRIWKH
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QHXURORJLVW¶VSDWLHQWYiew elicitor (lines 108 and 110) with a request for his 
professional opinion, displaying an understanding that what has unfolded is not 
hearable as a recommendation.  In resisting making a choice, he is recognising that a 
choice has been offered (see also Anonymous).  
 
These contrasting cases demonstrate ± in practice ± the distinction between having a 
choice and making one.  Following both consultations, patient and neurologist 
reported that a choice had been offered.  Our data indicate, then, that option-listing 
does not lose its capacity to generate the perception of choice even if the neurologist 
makes the decision. 
 
A hybrid practice: replacing the PVE with a recommendation 
Extract 3 shows how option-listing can be adapted (see also Anonymous).  The 
neurologist produces the first two components (see lines 9-15).  Thereafter, however, 
he deviates from the pattern shown above.  In place of a patient view elicitor 
(component 3) ± which could have been produced at lines 16-18 ± he makes a 
recommendation for the second option (lines 17-18).  Thus, rather than opening up 
space for the patient to make a selection, the neurologist transforms the list into a 
proposal, to be accepted or resisted.  Moreover, he moves quickly (line 18) into 
further information provision (projected by a marked in-breath), thereby leaving no 
room for a verbal response.  
 
Extract 3 
G09701: diagnosis unknown; possibly small vessel cerebrovascular disease 
01   Neu:   No:w .hh the difficulty is you had this test done for 
VRPHWKLQJHOVHDQGLW¶VWXUQHGXSDQRWKHU\RXNQRZDQ 
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XQH[SHFWHG>ILQGLQJ>VRZH¶UHOHIWZLWKDQDEQRUPDO 
04   Pat:              [Yeah     [yeah. 
1HXWHVWUHVXOWZKHUHDV\RXGRQ¶WKDYHDQ\NLQGRI 
06          disease .hhh symptoms to go with [that.  
07   Pat:                                    [Mhm 
08          (0.4) 
09   Neu:   8PWDQGWKHUH¶UHDFRXSOH of options he:re.  
10          (0.2) .hhh We could jus:t (0.3) not do anything, [hh.  
11   Pat:                                                    [Mhm 
12   Neu:   (UDQGVD\³WKHVHDUH LQFLGHQWDOILQGLQJV QRWOHW- (.)  
13          OHW¶VQRWZRUU\DERXW them,´ .hhhh We could take it a  
14          little bit further and- and investiga:te, (.) #for# (0.6)  
15          possible causes of this:,  
16          (0.2) 
17 Æ  Neu:  U::m and (0.1) er that- WKDW¶Vprob¶O\ZKDW,  
18 Æ        would recommend doing. .HHHhh No::w as I said (0.3)  
19          these look (.) like (0.6) areas where the blood supply to 
WKHEUDLQLVQ¶WDVJRRGDVLWshould EHWKH\GRQ¶WORRN 
21          like areas of inflammation. 
22   Pat:   Mhm 
23   Neu:   But .hhhh (0.3) really I think to investigate this fully  
ZKDW,¶GOLNHWRGRLVDQXPEHURIEORRGWHVWV 
25   Pat:   Mhm 
26   Neu:   .hh And also do a thing called a lumbar puncture. 
27          (0.2) 
28   Pat:   Yeh. 
29   Neu:   U::m that involves taking some spinal fluid out of the  
EDFNXQGHUORFDODQDHVWKHWLF LW¶VDYHU\VWUDLJKWIRUZDUG 
31          proc[edure. 
32   Pat:       [Okay 
33   Neu:   .HHHHhh But it would allo:w us to (0.4) know whether  
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34          these are inflammatory or not.=As I said looking at the  
VFDQWKH\GRQ¶WORRNOLNHLQIODPPDWLRQ  
36   Pat:   =Okay 
1HX%XWLW¶VDZD\RIEHLQJPRUHVXUH  
38   Pat:   =Ye[h. 
39   Neu:      [.hhhh A::nd the blood test (we l-)/(really) that we  
40          (.) would do would be to look for causes of (0.5) you  
41          know premature what we call vascular disease or (0.2) you  
42          know (0.2) conditions that can affect the blood vessels. 
43          (0.1) 
44   Neu:   .hh Um there are various (0.6) what we call (0.3)  
45          vasculitides or vasculitis which can do tha:t but [.hhhhh  
46   Pat:                                                     [Yeh         
47   Neu:   (I-WKDW¶VZKDW,ZRXOGVXJ>JHVWZHGR LIHYHU\WKLQJ 
48   Pat:                               [>Okay<   
FRPHVEDFNQRUPDOLW¶VUHDVVXULQJ 
50   Neu:   w[e doQ¶WQHHGWRGRDQ\WKLQJIXUWKHU 
51   Pat:    [Yeah 
52          (0.4) 
53   Pat:   (The) what kinda time factor is involved? (.) in these  
54          test thing(s) (doctor) 
 
5HVSRQGLQJWRWKHQHXURORJLVW¶VHODERUDWLRQRIDQGDFFRXQWIRUKLVUHFRPPHQGDWLRQ
the patient produces minimal acknowledgements (lines 22, 25), several more overtly 
aligning acknowledgements (lines 28, 36, 38, 46 and 51), and some indicators of 
accepting the recommendation (lines 32 and 48).  He does not voice a view or treat 
himself as selecting from the list.  When he produces a fuller turn (lines 53-54) this is 
to ask about the timing of the tests.  This foreshadows a question about his life 
insurance rather than any resistance.  By replacing the third component of option-
 18 
listing with a recommendation, the neurologist significantly alters the way in which 
the option-listing functions ± from creating a moment of choice for the patient, to 
proposing that a (professional) conclusion about what is best has already been 
UHDFKHG7KLVLVUHIOHFWHGLQWKHSDWLHQW¶VDFFHSWLQJUHVSRQVH  It is striking, 
therefore, that even in this case, neurologist and patient agreed that choice was offered 
± which was true also of other cases in which a recommendation was made in 
conjunction with option-listing (see Extract 16 in Anonymous).  
 
Using option-listing to pursue acceptance of a recommendation 
In Extract 3, WKHQHXURORJLVW¶VSUHIHUHQFHZDVVRPHZKDWLQGH[HGLQKRZKHpresented 
the options: WKHPLQLPLVLQJµMXVW¶DWOLQHDQGWKHLPSOLHGULVNof missing a serious 
disease make it hearable, before the explicit recommendation, that he is likely to 
endorse further testing.  Nevertheless, he provides some basis for choosing to do 
nothing: the patient has no symptoms and these findings arose by chance when testing 
for something else (lines 1-6).  Moreover, he makes no overt recommendation prior to 
the option-listing.  Extracts 4a-b, by contrast, show a decision sequence that begins 
with a recommendation, acceptance of which the neurologist pursues repeatedly, 
before using option-listing (see also Anonymous).  The recommendation is to monitor 
WKHSDWLHQW¶VXQGLDJQRVHGµWXUQV¶ (lines 1-2 and 8-FRQYH\HGDVWKHQHXURORJLVW¶V
view ³,WKLQN´OLQHDQG-8) on what is best.  It is given extra weight through the 
imperative, ³ZHKDYHWR´ (lines 1 and 8).  The neurologist does not, at this stage, raise 
the option of doing nothing.  Although his proposal to try home monitoring (lines 9-
11) is mitigated by the ³,ZRQGHULI´FRQVWUXFWLRQCurl and Drew 2008), the question, 
for him, is clearly how best to monitor (not whether to). 
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Extract 4a 
G00604: Could be epilepsy or non-epileptic seizures 
01   Neu:   >.hh< Right. I think what we have to do he:re. is (1.0)  
02          e:r how- how long were you in ((centre name1)) before, 
03   Mum:   A mont[h. 
04   Pat:         [A month.= 
05   Neu:   =A month alright. 
06   Pat:   [Yea::h. 
            [((Patient is focused on her seizure diary and  
            appears to be about to start another turn when  
            Neurologist starts speaking))  
07   Neu:   Well (.) I hesitate to do that again but (.) I think  
08          (0.2) I mean- I mean I think we have to try and record  
09          some of these turns. .hh And I wonder if the best way to  
10          do it would be to give you a wee monitor to go ĹKRPH 
11          with,  
12          [(0.8)  
            [((Patient moves towards Neurologist, holding out diary))  
13   Neu:   What do yo[u think of that. 
14   Pat:             [(Basically)  
15          (0.4) 
16   Pat:   (wa::y) is (happening is) .hh I have a few days o:[:ff.     
            ((During lines 14-16, Patient shows Neurologist her  
            UHFRUGRIKHUµWXUQV¶ 
17   Neu:                                                     [Aye. 
18          (0.5)    
19   Pat:   Few days o:n. 
20   Neu:   Right. 
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The patient has a mild learning difficulty, which may partially account for how she 
and the neurologist pursue parallel agendas.  Here, she is consulting her seizure diary, 
used earlier to WU\WRHVWDEOLVKKRZORQJVKHFDQJRZLWKRXWDµWXUQ¶6KHpursues this 
as the neurologist tries to move on to what to do next (lines 6-13).  In the absence of a 
fitted response to his recommendation (which could have occurred at line 12), the 
neurologist seeks WKHSDWLHQW¶VYLHZOLQH+er response remains rooted in how 
RIWHQVKHH[SHULHQFHVKHUµWXUQV¶OLQHV-16).  This misalignment continues in a 
manner that could be understood as resistance to monitoring (data not shown).  What 
matters, for our purposes, is that the neurologist employs option-listing only after he 
KDVIDLOHGWRVHFXUHWKHSDWLHQW¶VDFFHSWDQFHRIKLVUHFRPPHQGDWLRQ 
 
We rejoin the interaction at a point where the neurologist is trying (again) to gain this 
acceptance (Extract 4b, lines 57-63).  He looks VHWWRUHLVVXHKLVUHFRPPHQGDWLRQ³\- 
\RXFRXOG´OLQH57) but instead provides a justification, strongly positioning the 
recommended investigation as a necessary precursor to treatment (lines 57-63).  He 
then employs a condensed but clear version of option-listing.  At lines 65-66, he flags 
up that there is a decision to be made, placing WKLVLQWKHSDWLHQW¶VGRPDLQ³you need 
to decide what you would like XVWRGR´FRPSRQHQW+HWKHQOLVWVWZRRSWLRQV
formatted as an interrogative (lines 66-70), thereby folding the action of listing 
FRPSRQHQWDQGVHHNLQJWKHSDWLHQW¶VYLHZFRPSRQHQWLQWRRQHXQLW 
 
Extract 4b 
G00604 
57   Neu:   E:r (0.4) y- \RXFRXOGFRXJKVµFRVDWWKHHQGRI 
58          the da::y (0.2) basically if we can record these turns we  
PD\EHDEOHWRKHOS\RXEXWLIZHFDQ¶WUHFRUG 
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WKHVHWXUQVZH¶UHSUREDEO\not going to be able to  
61          help you, (0.4) So: ((clears throat)) and- and we  
ZRXOGQ¶WEHEULQJLQJ\RXEDFNDQGIRUWKWRWKHFOLQLFLI 
ZHFDQ¶WKHOS\RXREYLRXVO\ 
64          (.) 
65   Neu:   .hh So: what we need to do:: er clearly is you need to  
66          deci:de (.) what- ZKDW\RXZRXOGOLNHXVWRGR G¶\RX 
67          ZDQWXVWRNHHSWU\LQJWRUHFRUGWKHPVRZH¶UH 
68          (0.2) completely sure what everything is and we can (0.2)  
69          maybe treat ĹWKHPRUG¶\RXZDQt to: (0.2) kind of  
70          (1.0) just soldier on as you a:re. 
71          (.) 
1HX\RX>µFRV 
73   Mum:        [1REHFDXVHLW¶VNLQGRIXKLWWDNH-)  
74          (containing) me to whe::re .hh what I can do::,  
75   Neu:   Mhm. 
(Neurologist pursues Patient¶VYLHZWKH\UHVROYHDPLQRUPLVXQGHUVWDQGLQJDQGVKHLQGLFDWHVWKDWVKH
GRHVQRWZDQWWRµVROGLHURQ¶ 
 
103  Neu:   Yeah (okay). :HOOG¶\RXZDQWXVWRGRVRPH 
104         recordings then to see what we [can find out 
105  Mum:                                  [Yea::h. 
106  Pat:   See what you can do(h.), 
1HX<HDKRND\,¶OODUUDQJHWKDWWKHQ 
 
The design of the options is clearly not neutral.  In constructing the option of 
monitoring, the neurologist not only upgrades its utility (line 68), but makes treatment 
contingent on this investigation (lines 68-69).  Moreover, the alternative is set up as 
unsatisfactory for the patientKDYLQJWR³soldier on´ entails coping in the face of 
adversity, which could be lessened if they identified an appropriate treatment.  
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0RUHRYHUWKLVDPRXQWVWRµGRLQJQRWKLQJ¶ZKLFKFRXOGEHDUJXHGWRFRQVWUXFWOLWWOH
choice.  The terms of the decision are set, then, to make it difficult to bid for no 
monitoring.  Although the neurologist has used the machinery of option-listing, he has 
done so in a way that constructs another version of his recommendation, pursuing 
acceptance thereof.  
 
Mum addresses the second option as if it were a single yes/no question2, rejecting it 
OLQHDQGDFFRXQWLQJIRUWKLVLQWHUPVRIKHUFRQFHUQV7KHXSIURQW³QR´VXJJHVWV
WKDWWKLVLVSURGXFHGDVDQDOLJQPHQWZLWKWKHQHXURORJLVW¶VSRVLWLRQWKDWFRQWLQXLQJ
as they are is not the best option (see Pomerantz and Heritage 2013).  Thus, she 
displays an understanding that the two options are not equally weighted.  The 
QHXURORJLVWWKHQVHHNVWKHSDWLHQW¶VDJUHHPHQWXVLQJDQRWKHUPVE, the eventual 
upshot of which is an agreement by the patient that she also wants to find a solution.  
The neurologist finally secures a clear agreement from Mum (line 105) and patient to 
undertake testing (line 106).  
 
Comparing Extracts 1 and 4a-b, we see the malleability of option-listing.  Although 
both produce a list from which the patient may choose, the neurologist in 1 constructs 
viable alternatives, whereas the neurologist in 4b uses option-listing to pursue 
acceptance of his recommended option.  Nevertheless, in their post-consultation 
questionnaires, participants in both reported that a choice had been offered3. Thus, 
even when option-OLVWLQJZDVXVHGLQDZD\WKDWVHHPVWRVWUHWFKWKHOLPLWVRIµFKRLFH¶
close to breaking point, it was reportedly perceived as making choice available.  
 
A deviant case 
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Extract 5 shows a deviant case in that the neurologist reported that a choice had been 
offered, and the patient that it had not.  The patient has long-standing epilepsy, which 
is not fully controlled.  The neurologist has concluded that they should reduce one of 
her anti-epileptics because it appears to be causing fatigue and not improving seizure 
control.  The question is what else they might try.  The neurologist makes a bad news 
announcement: they have, more or less, run out of alternatives DQG³WKHFKDQces of 
JHWWLQJ>KHU@VHL]XUHIUHHDUHUHDOO\YHU\ORZLQGHHG´.  Implicitly, he is recommending 
continuing with her current medication.  In this regard, his turn is comparable to cases 
in our no-choice subset (i.e. Subset 4, Table 1), which typically involved 
recommendations for doing nothing or nothing new (Anonymous).  
 
Against this backdrop, the neurologist uses option-listing.  In Extract 5, we see the 
familiar three components.  He flags up that a decision is to be made (line 15), lists 
two alternatives (lines 15-16 and 18-22), places the decision LQWKHSDWLHQW¶VGRPDLQ
(lines 15 and 23-24), and uses a PVE to hand the decision to the patient (lines 38-39).  
When this fails to elicit a response (line 40), the neurologist returns to his original 
position: that he has little to offer.   
 
Extract 5  
G08904 
15   Neu:  E:r (0.5) DQGLW¶VXSWR\RXDELWXPKK some people  
16         VD\³ZHOOORRN,QHHGWRWU\HYHU\GUXJ´ 
17         (0.5) 
18   Neu:  Er (I-) you know (0.1) whatev[e:r, e:r other (0.1)  
19  (Hus):                              [Mm  
20   Neu:  SDWLHQWVVD\³ZHOO\RXNQRZ#I:: # ,¶YH  
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21         been through all this befo:re (0.1) side effects upse:t  
22         DOOWKDWVRUWRIWKLQJKKK,¶OOVWLFNZKHre I ĹDP´  
23         .hhh And it depends a wee bit on you: (0.3) you know what  
24         your attitude is. KKK7KHUH¶UHcertainly a couple of  
25         medications there we could try::, What are the chances  
WKH\¶OOZRUN"Quite low. 
 
1HXURORJLVWVSHFLILHVWKDWWKHFKDQFHVDUH³RIWKHRUGHURIDFRXSOHRISHUFHQW´ 
 
38   Neu:  But not zero, (0.1) VRLW¶VUHDOO\XSWR\RXZKHWKHU\RX  
39         want to try them or not.  
40         (0.8) ((Pat looks at neu)) 
 
(Neurologist further explicates the low chance of achieving full seizure freedom) 
 
92   Neu:     [(But) I- I- I mean if you do want to try them .hh you  
93         know I have to be realistic with you and sa:y, you know  
94         (0.2) the- the chances of them actually helping you out  
95         are- are really pretty low. 
96         (0.2) 
97   Pat:  Yea:h. 
98   Neu:  U:m .hh er just (0.4) you know and there is a downside to  
WU\LQJQHZWDEOHWV 6R>LW¶V- LW¶VLW¶Vyour choice. 
100  Hus:                         [Mm::: yea:h. 
101        (1.3) 
102  Pat:  KK,IWKDW¶VWKHFDVHWKHQ,¶PDVZH>OOMXVW 
103  Hus:                                       ><RX¶YHMXVWJRWWD  
104        live with the: 
105  Neu:  M[m 
106  Hus:   >VLWXDWLRQ\RX¶YHJRW 
107        (0.4) 
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108  Neu:  .h[hh 
109  Pat:    >,MXVWQHHGWRVW>LFNZLWKWKHVL>WXDWLRQ,¶YH  
110  Neu:                      [ºYeah.º        [ºYeah.º 
111  Pat:  [got [(aye) 
112  Hus:  [Mhm 
113  Neu:       [ºOkayº 
 
The disagreement in the neurologist¶V DQGSDWLHQW¶VVHOI-report data is evident within 
the consultation.  The neurologist frames WKHGHFLVLRQDVWKHSDWLHQW¶V³FKRLFH´OLQH
99), but the patient and her husband construct it starkly as a non-choice, using the 
imperatives: ³gotta live with [it]´(line 103) DQG³need to stick with the situation]´.  
The use of option-listing ± DQGHYHQWKHSKUDVH³LW¶V\RXUFKRLFH´ ± does not, then, 
guarantee that patients will experience themselves as having genuine alternative 
options.   
 
However, this was the only case (for which we have valid data) where option-listing 
was used to generate a decision about a test, treatment or referral that was not 
perceived by the patient as offering choice.  What distinguishes this from the rest?  Its 
unique feature lies in what it lacks: the construction of any option as likely to address 
WKHSDWLHQW¶VWURXEOH&KRLFHLVWKHUHLQWKHIRUPDOVHQVHWKHSDWLHQWLV, as the 
neurologist reports, given the option to try an alternative drug.  However, choice is 
not there, as the patient reports, in a substantive sense: no option is presented as likely 
to make any difference (see also Anonymous).   
 
Discussion 
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Based on 223 neurology FRQVXOWDWLRQVDQGSDUWLFLSDQWV¶VHOI-reports following these, 
we have demonstrated that choice can be hearably offered through option-listing.  Our 
evidence takes two forms: first, option-listing was the only practice identified as 
characteristic of those consultations in which neurologists and patients agreed ± in 
their self-reports ± that choice had been offered.  Second, analysis of the practice of 
option-listing shows how it can be used to create a moment of choice for the patient in 
the consultation.  However, we found that even when the patient resisted making the 
choice or the neurologist adapted the practice of option-listing in significant ways, 
participants still agreed that a choice was offered.  Our deviant case ± in which the 
neurologist said a choice was offered and the patient said not ± differed in one 
important respect: no option was constructed as likely to benefit the patient.  This 
sheds light on the limits of option-listing as a means of giving patients (the perception 
of) choice.  
 
Previous research has shown that patients report concern about choice performed as 
³DSROLWLFDOO\GULYHQER[-WLFNLQJH[HUFLVH´%DUQHWW et al. 2008: 611) and that 
clinicians can struggle to construct opportunities for independent choice (Pilnick 
2008).  One might, then, expect higher levels of disagreement about whether choice 
was offered, given that option-listing was used in ways that stretched the limits of 
ZKDWFRXOGEHDQDO\VHGDVµFKRLFH¶What are we to make of this?  It seems 
reasonable to consider option-listing to be a canonical method for offering choice.  
The menu is a ubiquitous example of option-listing in everyday service encounters, 
and versions of option-listing have been identified in offers of choice by carers to 
people with learning difficulties (Antaki et al. 2008).  Our findings may, therefore, 
reflect a mundane understanding that menus give choice ± even if highly constrained. 
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Patients may also understand option-listing as a practice for foregrounding their right 
to choose, even when the alternatives are not HYHQO\EDODQFHGHLWKHUµLQUHDOLW\¶± 
however we may judge that ± or in how the options are presented).  Thus, patients 
may, justifiably, hear themselves as having been offered a choice even if only one 
option was presented as a viable solution.   If so, there is a clear message for 
practitioners: option-listing is a robust practice for generating the perception of 
choice, provided at least one option offers potential benefit.  Whether clinicians 
should be generating such a perception (or under what circumstances) is, however, 
less clear.   
 
There are three main reasons for caution.  First, there is unresolved debate around 
whether having choice is necessarily better for patients.  Psychological research, 
indicating positive consequences of choice, has been invoked to support the patient 
choice DJHQGD)RUH[DPSOHVWXGLHVKDYHVKRZQLQFUHDVHG³LQWULQVLFPRWLYDWLRQWDVN
SHUIRUPDQFHOLIHVNLOOVDQGKLJKHURXWFRPHHYDOXDWLRQV´2JGHQ at al. 2008: 614), 
which, iQWULJXLQJO\KDYHEHHQIRXQG³WRRFFXUUHJDUGOHVVRIZKHWKHUFKRLFHLVDFWXDO
WULYLDORULOOXVRU\´LELG0RUHRYHU2JGHQ et al. (2008) showed that most 
participants rated having choice as beneficial.  However, some research has indicated 
that ± at least following extensive rather than limited choices ± SDUWLFLSDQWV¶OHYHOVRI
motivation and satisfaction were lower (in Ogden et al. 2008).  Ogden et al. also 
showed mixed responses when it came to making choices, with around two-thirds of 
the sample being unsure or negative about this.  Likewise, the consultants in Ford et 
DO¶V (2003: 597) study were generally critical of expecting patients to select from 
among RSWLRQVEHOLHYLQJWKDWWKH\³VKRXOGDGYLVHSDWLHQWVRQWKHEHVWFRXUVH of 
action for WKHP´7KLVFKLPHVERWKZLWKSDWLHQWV¶UHSRUWVWKDWFKRLFHFRXOGEH
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H[SHULHQFHGDVDWKUHDWWRWKHLU³IDLWKLQWKHH[SHUWLVHRIWKHGRFWRUDWDWLPHZKHQWKH\
were PRVWUHOLDQWXSRQLW´%DUQHWWHWDO2008: 612), and with our finding that some 
patients resisted making a choice and how WKH\GLGVRHJWKHSDWLHQW¶VIDWKHULQ
([WUDFWVRXJKWWKHQHXURORJLVW¶VSURIHVVLRQDORSLQLRQ4.  Moreover, even if there are 
benefits from having choice, it is unclear whether these extend to all patient groups 
equally (ibid).   
 
A second reason for caution lies in how choice is offered.  Based on our pilot work, 
we argued that, compared with recommending, option-listing works to reduce the 
exercise of medical authority E\SODFLQJWKHGHFLVLRQH[SOLFLWO\LQWKHSDWLHQW¶V
GRPDLQDQGDYRLGLQJWKHQHHGWR³work with (or against) an expert opinion of what is 
EHVW´Anonymous).  As we demonstrate here, option-listing can function in this way.  
But it need not.  If used as shown in Extract 4b, option-listing may function to pursue 
DFFHSWDQFHRIWKHQHXURORJLVW¶VSUHIHUUHGRSWLRQ.  Antaki and Kent (2015: 29) have 
identified a similar practice in adult-child LQWHUDFWLRQVHJ³ZRXOG\RXSXWWKHP
neatly in the corner for mummy plHDVHRUGR\RXZDQQDJRWREHG´7KH\DUJXHWKDW
E\RIIHULQJDOWHUQDWLYHVHQWDLOLQJ³DFKRLFHEHWZHHQWZRPDQLIHVWO\GLIIHUHQWO\
valenced FRXUVHVRIDFWLRQ´DGXOWVDUHissuing directives, with an accompanying 
threat of what will happen if these are not followed.  Similarly, in Extract 4b, having 
WR³soldier on´ with no help from the clinic is the threatened negative consequence of 
failure to undergo monitoring.  As Antaki and Kent (2015: 37) FRQFOXGH³WKH
interactional effect is that [such turns] seeminJO\SUHVHUYHWKHFKLOG¶VFKRLFHDQG
DJHQF\ZKLOHWLSSLQJWKHEDODQFHKHDYLO\LQIDYRXURIWKHDGXOW¶VSUHIHUHQFH´ 
 
Thus, if patients perceive option-listing as offering choice even when it is functioning 
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to seek their acceptance of a recommendation (particularly in the face of resistance), 
then option-listing may sometimes operate less as a practice for reducing authority 
and more as one for disguising its exercise.  Although there can be good reasons for 
persuading patients to do things they would rather not, such practices sit 
uncomfortably alongside the widespread endorsement of a more egalitarian 
relationship between doctors and patients.  Simply advocating the use of option-
listing carries no guarantee that it will produce a genuine moment of choice for the 
patient in practice.    
 
However, and this is the third reason for caution, it may be that the policy directive to 
LQFUHDVHµSDWLHQWFKRLFH¶LVDUHGKHUULQJThere is now a vast body of literature 
advocating a multi-faceted model RIµVKDUHGdecision-PDNLQJ¶ (SDM), which allows 
for significant patient involvement but also pushes back against a consumerist model, 
in which the patient is left to choose as if making a purely preference-based decision, 
like whether to order coffee or tea.  SDM emphasises interactional approaches that 
facilitate informed decision-making that balances WKHSDWLHQW¶VSUHIHUHQFHVDQGWKH
current state of medical evidence (e.g. Elwyn and Edwards 2009).  However, while 
SDM is widely accepted as an ideal, the policy literature slides between this broader 
FRQFHSWDQGPRUHVSHFLILFFDOOVIRULQFUHDVHGµSDWLHQWFKRLFH¶$QDO\VWVDQG
practitioners alike, then, need to be vigilant about what version of patient involvement 
is being (often implicitly) articulated.     
To our knowledge, our was the first study to focus on what constitutes, specifically, 
µpatient¶ FKRLFHIURPWKHGXDOSHUVSHFWLYHRISDUWLFLSDQWV¶VHOI-reports and close 
analysis of real decision-making.  Further research is needed to address the limitations 
of our study, which include the possibility that our findings could be specific to 
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neurology, to secondary care, to NHS practice, and/or to chronic disorders.  Future 
research might also seek more nuanced accounts of SDUWLFLSDQWV¶SHUFHSWLRQVRIFKRLFH
using interviews instead of brief questionnaires.  
 
This paper has focused on the only practice for giving patients choice that we 
identified as characteristic of those consultations in which participants agreed that a 
choice had been offered.  However, option-listing was not the only practice used to 
initiate decision-making in this subset.  Moreover, in roughly a third of our 
consultations neurologists and patients disagreed about whether choice had been 
offered.  It is clear, then, that what constitutes patient choice is far from self-evident.  
Given the extent to which NHS policy encourages clinicians to offer patients more 
choice, unpicking what this means in practice should be a priority.    
 
Notes 
1This centre offers inpatient monitoring to try to determine whether seizures are 
epileptic or psychogenic. 
 
2
 ,W¶VZRUWKQRWLQJthat one would expect the second option to be addressed first, as 
SHU6DFNV¶VILQGLQJVRQWKHSUHIHUHQFHIRU³contiguity in sequences in 
FRQYHUVDWLRQ´ 7KLVPD\DOVRFRQWULEXWHWRWKHXSIURQWSURGXFWLRQRIµQR¶ZLWK
thanks to an anonymous reviewer for this observation).   
 
3
 While we cannot rule out the possibility that the patient in Extracts 4a-b may have 
had limited understanding of the post-consultation questionnaire (given her mild 
learning difficulty), the questionnaires were completed with our Research Assistant 
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DQGWKHSDWLHQW¶VPXPSUHVHQWWRSURYLGHKHOSMoreover, there is evidence of 
sufficient understanding LQWKHSDWLHQW¶VRWKHUDQVZHUVIRUXVWRconsider this to be a 
valid representation of her perception of choice. 
  
4With thanks to an anonymous reviewer for this observation. 
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Figure 1. Number of recordings collected overall, key practices analysed for wider 
project, and consultations included in the analyses reported here 
223 consultations 
x 223 patients (114 in Glasgow, 109 in Sheffield) 
x 120 accompanying others 63 in Glasgow, 51 in Sheffield) 
x 14 neurologists (7 at each site) 
144 consultations with one or more decision initiated by 
the neurologist using one of the key practices
131 contained one 
or more 
recommendation
24 contained  
one or more 
option-list 
77 contained  
one or more patient 
view elicitor 
5 excluded due to missing or invalid data 
19 consultations containing one or more option-list, 
conducted by 9 neurologists, analysed for this paper 
